These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 6502004)
21. Serum opsonin, bacteria, and polymorphonuclear leukocyte interactions in subacute bacterial endocarditis. Anti-gamma-globulin factors and their interaction with specific opsonins. Messner RP; Laxidal T; Quie PG; Williams RC J Clin Invest; 1968 May; 47(5):1109-20. PubMed ID: 5645856 [TBL] [Abstract][Full Text] [Related]
22. Opsonic activity in serum from septic infants treated with intravenous immunoglobulin. Maródi L; Kalmár A; Szabó I Arch Dis Child; 1989 Apr; 64(4):530-4. PubMed ID: 2751327 [TBL] [Abstract][Full Text] [Related]
23. Opsonic activity in human serum deficient in C2. Johnson FR; Agnello V; Williams RC J Immunol; 1972 Jul; 109(1):141-5. PubMed ID: 4402482 [No Abstract] [Full Text] [Related]
24. Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Mikolajczyk MG; Concepcion NF; Wang T; Frazier D; Golding B; Frasch CE; Scott DE Clin Diagn Lab Immunol; 2004 Nov; 11(6):1158-64. PubMed ID: 15539522 [TBL] [Abstract][Full Text] [Related]
25. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use. van Furth R; Leijh PC; Klein F J Infect Dis; 1984 Apr; 149(4):511-7. PubMed ID: 6202804 [TBL] [Abstract][Full Text] [Related]
26. Opsonic fibronectin is necessary for optimal serum-mediated phagocytosis of Staphylococcus aureus by human neutrophils. Lanser ME; Saba TM Adv Shock Res; 1982; 8():111-7. PubMed ID: 7136937 [TBL] [Abstract][Full Text] [Related]
28. Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. Fick RB; Naegel GP; Squier SU; Wood RE; Gee JB; Reynolds HY J Clin Invest; 1984 Jul; 74(1):236-48. PubMed ID: 6429195 [TBL] [Abstract][Full Text] [Related]
29. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. Bredius RG; de Vries CE; Troelstra A; van Alphen L; Weening RS; van de Winkel JG; Out TA J Immunol; 1993 Aug; 151(3):1463-72. PubMed ID: 8335940 [TBL] [Abstract][Full Text] [Related]
30. [Serum opsonic activity in newborns and through the first year of life (author's transl)]. Pedraz C; Lorente F; Pedraz MJ; Salazar V An Esp Pediatr; 1980 Jul; 13(7):577-82. PubMed ID: 7416648 [TBL] [Abstract][Full Text] [Related]
31. Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence. Munro CS; Stanley PJ; Cole PJ Clin Exp Immunol; 1985 Jul; 61(1):183-8. PubMed ID: 3930107 [TBL] [Abstract][Full Text] [Related]
32. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Bortolussi R; Fischer GW Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443 [TBL] [Abstract][Full Text] [Related]
33. [Studies on an extract from Haemophilus influenzae type a. II.--Phagocytic capacity of sera obtained from rabbits immunized by this bacterial extract (author's transl)]. Raichvarg D; Brossard C; Agneray J Pathol Biol (Paris); 1980 May; 28(5):299-303. PubMed ID: 6992066 [TBL] [Abstract][Full Text] [Related]
34. Opsonization requirements of Serratia marcescens. Traub WH Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137 [TBL] [Abstract][Full Text] [Related]
35. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi. Lagergård T; Frisk A; Purvèn M; Nilsson LA Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597 [TBL] [Abstract][Full Text] [Related]
36. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Håkansson L; Hällgren R; Venge P Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589 [TBL] [Abstract][Full Text] [Related]
37. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin. Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285 [TBL] [Abstract][Full Text] [Related]
38. Pneumococcus-induced serotonin release from human platelets. Identification of the participating plasma/serum factor as immunoglobulin. Zimmerman TS; Spiegelberg HL J Clin Invest; 1975 Oct; 56(4):828-34. PubMed ID: 239970 [TBL] [Abstract][Full Text] [Related]
39. Opsonic and physicochemical characteristics of intravenous immunoglobulin preparations. van Furth R; Braat AG; Leijh PC; Gardi A Vox Sang; 1987; 53(2):70-5. PubMed ID: 3500539 [TBL] [Abstract][Full Text] [Related]
40. Bactericidal and opsonic properties of C4-deficient guinea pig serum. Root RK; Ellman L; Frank MM J Immunol; 1972 Sep; 109(3):477-86. PubMed ID: 4403402 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]